Hasselt University / Universiteit Hasselt

University / College


Location: Hasselt / Diepenbeek, Belgium (BE) BE

ISNI: 0000000106045662

ROR: https://ror.org/04nbhqj75

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

FESTUNG: A MATLAB/GNU Octave toolbox for the discontinuous Galerkin method. Part III: Hybridized discontinuous Galerkin (HDG) formulation (2018) Jaust A, Reuter B, Aizinger V, Schütz J, Knabner P Journal article, Original article Salt-responsive gut commensal modulates TH17 axis and disease (2017) Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H, Haase S, et al. Journal article Catalyst Stability Benchmarking for the Oxygen Evolution Reaction: The Importance of Backing Electrode Material and Dissolution in Accelerated Aging Studies (2017) Geiger S, Kasian O, Mingers AM, Nicley SS, Haenen K, Mayrhofer K, Cherevko S Journal article Absorption tails of donor:C60 blends provide insight into thermally activated charge-transfer processes and polaron relaxation (2017) Vandewal K, Benduhn J, Schellhammer KS, Vangerven T, Rueckert JE, Piersimoni F, Scholz R, et al. Journal article Derivation of an Effective Model for Metabolic Processes in Living Cells Including Substrate Channeling (2017) Gahn M, Neuss-Radu M, Knabner P Journal article, Original article Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation (2017) Hammer A, Schliep A, Joerg S, Haghikia A, Gold R, Kleinewietfeld M, Mueller DN, Linker R Journal article SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR EFFICACY AND SAFETY RESULTS FROM PHASE 3 FUTURE 1 TRIAL (2017) Mease PJ, Kavanaugh A, Reimold A, Tahir H, Rech J, Hall S, Geusens P, et al. Conference contribution SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS (PSA) THROUGH 3 YEARS: EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL (2017) Hall S, Mease P, Kavanaugh A, Reimold A, Tahir H, Rech J, Geusens P, et al. Conference contribution Homogenization of a pore scale model for precipitation and dissolution in porous media (2016) Neuss-Radu M, Pop IS, Kumar K Journal article A characterization of relatively compact sets in Lp(Ω,B) (2016) Gahn M, Neuss-Radu M Journal article, Original article
1 2 3 4 5